Allison Dillon

Dr. Dillon is currently Vice President of Commercial and Portfolio Strategy. Prior to joining Calithera in 2017, Dr. Dillon was at Genentech, where she gained extensive oncology experience in pre- and post-launch commercialization strategy and execution. Most recently, Dr. Dillon led the marketing team for Tecentriq in GU cancers, overseeing the US promotional launch planning and execution, and the global branding. She supported life cycle management, pipeline strategy and development in global business teams. She has served in marketing and sales roles for Avastin, Tarceva, Zelboraf, and Tecentriq with increasing responsibility across numerous indications. Prior to Genentech, Dr. Dillon was a Senior Consultant at Campbell Alliance where she worked across multiple disease areas with clients on commercial strategy projects. She completed a postdoctoral fellowship at the University of California, San Francisco studying genetic pathways in medulloblastoma. Dr. Dillon holds a Ph.D. in Neuroscience from Albert Einstein College of Medicine, and a B.A. in Psychology from the University of Richmond.